JACC. Clinical electrophysiology最新文献

筛选
英文 中文
Fixed Knotting of Looped Pulsed Field Ablation Catheter due to Tip Inversion Without Guidewire Retraction.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-29 DOI: 10.1016/j.jacep.2024.11.022
Suguru Nishiuchi, Yuji Matsuo, Shingo Yoshimura, Akiko Kodama, Taiki Masuyama, Kenichi Kaseno, Takehito Sasaki, Kohki Nakamura, Shigeto Naito
{"title":"Fixed Knotting of Looped Pulsed Field Ablation Catheter due to Tip Inversion Without Guidewire Retraction.","authors":"Suguru Nishiuchi, Yuji Matsuo, Shingo Yoshimura, Akiko Kodama, Taiki Masuyama, Kenichi Kaseno, Takehito Sasaki, Kohki Nakamura, Shigeto Naito","doi":"10.1016/j.jacep.2024.11.022","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.11.022","url":null,"abstract":"","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sudden Cardiac Arrhythmic Arrest: A Pivot to the Past.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-29 DOI: 10.1016/j.jacep.2024.11.008
Kurt S Hoffmayer, Melvin M Scheinman
{"title":"Sudden Cardiac Arrhythmic Arrest: A Pivot to the Past.","authors":"Kurt S Hoffmayer, Melvin M Scheinman","doi":"10.1016/j.jacep.2024.11.008","DOIUrl":"10.1016/j.jacep.2024.11.008","url":null,"abstract":"","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients: Temporal Trends and Clinical Outcomes.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-23 DOI: 10.1016/j.jacep.2024.12.004
Marco Bergonti, Philipp Krisai, Ciro Ascione, Thomas Pambrun, Domenico G Della Rocca, Paolo Compagnucci, Tardu Özkartal, Lorenzo Marcon, Teba Gonzalez Ferrero, Luigi Pannone, Michael Kühne, Matteo Anselmino, Michela Casella, Teodor Serban, Claudio Tondo, Moises Rodríguez-Mañero, Maria Luce Caputo, Patrick Badertscher, Nicolas Derval, Carlo de Asmundis, Gian Battista Chierchia, Hein Heidbuchel, Pierre Jaïs, Angelo Auricchio, Andrea Sarkozy, Giulio Conte
{"title":"Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients: Temporal Trends and Clinical Outcomes.","authors":"Marco Bergonti, Philipp Krisai, Ciro Ascione, Thomas Pambrun, Domenico G Della Rocca, Paolo Compagnucci, Tardu Özkartal, Lorenzo Marcon, Teba Gonzalez Ferrero, Luigi Pannone, Michael Kühne, Matteo Anselmino, Michela Casella, Teodor Serban, Claudio Tondo, Moises Rodríguez-Mañero, Maria Luce Caputo, Patrick Badertscher, Nicolas Derval, Carlo de Asmundis, Gian Battista Chierchia, Hein Heidbuchel, Pierre Jaïs, Angelo Auricchio, Andrea Sarkozy, Giulio Conte","doi":"10.1016/j.jacep.2024.12.004","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.12.004","url":null,"abstract":"<p><strong>Background: </strong>Catheter ablation of atrial fibrillation has been proven beneficial in patients with heart failure and reduced ejection fraction (HFrEF). On top of pulmonary vein isolation (PVI), additional ablation strategies such as empirical lines/posterior box/low voltage ablation (PVI+L/LVA) are often used. Whether PVI+L/LVA provides additional benefits in this population has never been systematically investigated.</p><p><strong>Objectives: </strong>This study sought to analyze the temporal trends and comparative outcomes of PVI+L/LVA vs PVI alone.</p><p><strong>Methods: </strong>Patients with HFrEF undergoing atrial fibrillation ablation were retrospectively enrolled. The 2 coprimary endpoints were ventricular function recovery and atrial fibrillation recurrence-free survival at 1 year. The performance of PVI and PVI+L/LVA was compared in the overall population and in 2 matched groups. A sensitivity analysis for measured confounders was performed.</p><p><strong>Results: </strong>A total of 955 HFrEF patients (62.1 years, 24.4% female) from 9 international centers were included (PVI only 51.6% vs PVI+L/LVA 48.4%). At 12 months after the procedure, 62.3% of the patients remained free from arrhythmia recurrences and 65.4% experienced ventricular function recovery. Comparing PVI to PVI+L/LVA, no significant difference in the 2 coprimary endpoints was observed, neither in the overall nor in the matched cohorts. The use of PVI+L/LVA increased from 27% in 2013 to 68% in 2022. Patients undergoing PVI+L/LVA experienced more complications (3.8 vs 1.2%; P = 0.018).</p><p><strong>Conclusions: </strong>Catheter ablation is associated with significant improvements in systolic function, irrespective of the ablation strategy used. The use of PVI+L/LVA in HFrEF patients is progressively expanding over time. Although the benefits of this practice remain unproven, it is associated with an increased risk of overall and nonvascular complications. These results warrant caution regarding the growing use of PVI+ in HFrEF patients.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal Trial.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-20 DOI: 10.1016/j.jacep.2025.01.001
Hursh Naik, Matthew J Price, Samir Kapadia, Brian K Whisenant, Peter Tadros, Raj Makkar, Anita W Asgar, Neil Fam, Gilbert H L Tang, Shamir R Mehta, Timothy Byrne, Gagan Singh, Sidakpal S Panaich, Kelli Peterman, Phillip M Trusty, Nadira Hamid, Rebecca T Hahn, David H Adams, Paul Sorajja
{"title":"Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal Trial.","authors":"Hursh Naik, Matthew J Price, Samir Kapadia, Brian K Whisenant, Peter Tadros, Raj Makkar, Anita W Asgar, Neil Fam, Gilbert H L Tang, Shamir R Mehta, Timothy Byrne, Gagan Singh, Sidakpal S Panaich, Kelli Peterman, Phillip M Trusty, Nadira Hamid, Rebecca T Hahn, David H Adams, Paul Sorajja","doi":"10.1016/j.jacep.2025.01.001","DOIUrl":"https://doi.org/10.1016/j.jacep.2025.01.001","url":null,"abstract":"<p><strong>Background: </strong>Patients with tricuspid regurgitation (TR) frequently have transvalvular cardiac implantable electronic device (CIEDs).</p><p><strong>Objectives: </strong>The aim of this study was to determine the safety and efficacy of tricuspid transcatheter edge-to-edge repair in patients with transvalvular CIED leads.</p><p><strong>Methods: </strong>The TRILUMINATE (Trial to Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System) Pivotal Trial (NCT03904147) is an international randomized, controlled trial in symptomatic subjects with severe TR. Subjects with CIED leads were screened by an eligibility committee prior to inclusion into the randomized or single-arm cohorts. Safety events were adjudicated by an independent review committee. All echocardiograms were analyzed by an independent core laboratory.</p><p><strong>Results: </strong>A total of 98 subjects (of 469) with attempted TriClip procedures had transvalvular CIED leads. CIED+ subjects were older (80.2 ± 8.6 years vs 78.2 ± 7.6 years; P = 0.02), with a higher prevalence of renal disease (46.9% vs 31.5%; P = 0.004) and lower health status (Kansas City Cardiomyopathy Questionnaire overall summary score 51.9 ± 21.0 vs 55.0 ± 23.1) at baseline compared with CIED- subjects. Slightly fewer clips were implanted in CIED+ subjects (mean 1.9) than in CIED- subjects (mean 2.2) (P = 0.0018). Procedural times were significantly shorter in CIED+ subjects (132.9 ± 63.3 minutes vs 155.9 ± 71.9 minutes; P = 0.0043) although greater in those with lead-induced TR (149.5 ± 87.5 minutes). Major adverse events (1.0% vs 1.1%) and major bleeding (3.1% vs 3.0%) were infrequent in CIED+ and CIED- subjects. At 30 days, TR reduction to moderate or less was similar in CIED+ and CIED- subjects (88% vs 87%) and was sustained out to 1 year in the majority of subjects (81% vs 84%). Compared with baseline, Kansas City Cardiomyopathy Questionnaire overall summary score significantly improved through 1 year in CIED+ subjects (18.7 ± 22.6; P < 0.0001) and CIED- subjects (16.8 ± 22.6; P < 0.0001). Heart failure symptoms were reduced in both groups at 30 days, with 85% of CIED+ subjects and 87% of CIED- subjects in NYHA functional class I or II. There were no differences in mortality, heart failure hospitalization, and need for tricuspid valve surgery or intervention between groups. No lead revisions, removals, or replacements were reported through follow-up.</p><p><strong>Conclusions: </strong>Tricuspid transcatheter edge-to-edge repair with the TriClip system was safe and effective in selected CIED+ subjects and did not affect CIED function. CIED+ subjects experienced similar TR reduction and quality-of-life improvements as CIED- subjects. Future work should define the treatable scope of patients with transvalvular CIED leads. (TRILUMINATE Pivotal Trial; NCT03904147).</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143189159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Transcatheter Edge-to-Edge Repair: An Approach Whose Time has Come for Electrophysiology. 三尖瓣经导管边缘到边缘修复术:一种时机已到的电生理学方法。
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-20 DOI: 10.1016/j.jacep.2025.01.002
Jamil Aboulhosn, Kalyanam Shivkumar
{"title":"Tricuspid Transcatheter Edge-to-Edge Repair: An Approach Whose Time has Come for Electrophysiology.","authors":"Jamil Aboulhosn, Kalyanam Shivkumar","doi":"10.1016/j.jacep.2025.01.002","DOIUrl":"https://doi.org/10.1016/j.jacep.2025.01.002","url":null,"abstract":"","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143189174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardioverter-Defibrillator Implantation as a Risk Factor For Motor Vehicle Crash.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-17 DOI: 10.1016/j.jacep.2024.12.002
John A Staples, Daniel Daly-Grafstein, Isaac Robinson, Mayesha Khan, Nathaniel M Hawkins, Herbert Chan, Shannon Erdelyi, Christian Steinberg, K Malcolm Maclure, Andrew D Krahn, Jeffrey R Brubacher
{"title":"Cardioverter-Defibrillator Implantation as a Risk Factor For Motor Vehicle Crash.","authors":"John A Staples, Daniel Daly-Grafstein, Isaac Robinson, Mayesha Khan, Nathaniel M Hawkins, Herbert Chan, Shannon Erdelyi, Christian Steinberg, K Malcolm Maclure, Andrew D Krahn, Jeffrey R Brubacher","doi":"10.1016/j.jacep.2024.12.002","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.12.002","url":null,"abstract":"<p><strong>Background: </strong>Limited empirical evidence informs fitness-to-drive recommendations after implantable cardioverter-defibrillator (ICD) implantation. Cohort designs can be deceptive because ICD recipients differ from control individuals and may temporarily cease driving after implantation.</p><p><strong>Objectives: </strong>This study sought to generate evidence to inform medical driving restrictions after ICD implantation.</p><p><strong>Methods: </strong>We used population-based data to identify all drivers involved in a serious motor vehicle crash in British Columbia, Canada, from 1997 to 2019. Exposure was defined as ICD implantation in the 6 months before a crash. One analysis used a case-crossover design to control for relatively fixed individual characteristics like driving experience. Another analysis used a responsibility design to account for road exposure (miles of driving per week). Both analyses used logistic regression with adjustment for potential confounders.</p><p><strong>Results: </strong>In the case-crossover analysis of crash-involved ICD recipients, ICD implantation occurred in 212 of 3,299 precrash intervals and in 485 of 6,598 control intervals, suggesting no temporal association between ICD implantation and subsequent crash (6.4% vs 7.4%; adjusted odds ratio [aOR]: 0.86; 95% CI: 0.71-1.03; P = 0.11). In the analysis of all crash-involved drivers with determinate crash responsibility, 14 of 22 drivers with recent ICD implantation and 532,741 of 1,035,433 drivers without recent ICD implantation were deemed responsible for their crash, suggesting no association between ICD implantation and crash responsibility (crude proportion responsible, 64% vs 51%; aOR: 2.20; 95% CI: 0.94-5.30; P = 0.08).</p><p><strong>Conclusions: </strong>The 6-month interval after ICD implantation is not associated with increased odds of crash nor with increased likelihood of crash responsibility. Contemporary driving restrictions in the first weeks after ICD implantation appear to adequately mitigate the potential increase in crash risk.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-16 DOI: 10.1016/j.jacep.2024.11.016
Chase M Fiore, Kate Quigley, Igor Vorobyov, Colleen E Clancy, Robert D Harvey
{"title":"Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K<sup>+</sup> Channel Activity.","authors":"Chase M Fiore, Kate Quigley, Igor Vorobyov, Colleen E Clancy, Robert D Harvey","doi":"10.1016/j.jacep.2024.11.016","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.11.016","url":null,"abstract":"<p><strong>Background: </strong>hERG encodes K<sub>V</sub>11.1 voltage-gated K<sup>+</sup> channels, which generate the rapidly activating delayed rectifier K<sup>+</sup> current that contributes to repolarization of the cardiac action potential. In addition to being targeted by many class III antiarrhythmic agents, these channels are also inhibited by a multitude of other pharmacological compounds, which can produce acquired long QT syndrome, leading to polymorphic ventricular tachycardia. While most drugs are thought to interact with a hydrophilic binding site in the channel pore, it has been postulated that some compounds act by perturbing the membrane environment or acting at hydrophobic sites accessed through the plasma membrane.</p><p><strong>Objectives: </strong>Because hERG channels reside in cholesterol rich lipid raft domains, we hypothesized that disrupting the membrane environment by depleting cholesterol might alter inhibition of channel activity by certain drugs.</p><p><strong>Methods: </strong>We tested our hypothesis by examining the effect that depleting membrane cholesterol with methyl-β-cyclodextrin has on the ability of several compounds to inhibit hERG channels expressed in HEK293 cells.</p><p><strong>Results: </strong>We found that cholesterol depletion significantly increased the sensitivity of the whole cell current to inhibition by ibutilide, while decreasing the currents sensitivity to dofetilide and amiodarone at negative membrane potentials.</p><p><strong>Conclusions: </strong>These results support the idea that the lipid environment of the plasma membrane plays a role in the ability of certain drugs to inhibit hERG channel activity. Differences in membrane cholesterol content may affect the ability of some hERG channel blockers to produce arrhythmogenic behavior.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bringing the Message Home: Remote Monitoring for Outpatient Initiation of Antiarrhythmic Drugs.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-15 DOI: 10.1016/j.jacep.2024.11.013
Thomas A Boyle, Timothy M Markman
{"title":"Bringing the Message Home: Remote Monitoring for Outpatient Initiation of Antiarrhythmic Drugs.","authors":"Thomas A Boyle, Timothy M Markman","doi":"10.1016/j.jacep.2024.11.013","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.11.013","url":null,"abstract":"","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole-Heart Histological and CMR Validation of Electroanatomic Mapping by Multielectrode Catheters in an Ovine Model.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-15 DOI: 10.1016/j.jacep.2024.11.011
Timothy Campbell, Richard G Bennett, Robert D Anderson, Chris Davey, Alexandra K O'Donohue, Aaron Schindeler, Kasun De Silva, Ashwin Bhaskaran, Samual Turnbull, Dinesh Selvakumar, Yasuhito Kotake, Chi-Jen Hsu, James J H Chong, Eddy Kizana, Saurabh Kumar
{"title":"Whole-Heart Histological and CMR Validation of Electroanatomic Mapping by Multielectrode Catheters in an Ovine Model.","authors":"Timothy Campbell, Richard G Bennett, Robert D Anderson, Chris Davey, Alexandra K O'Donohue, Aaron Schindeler, Kasun De Silva, Ashwin Bhaskaran, Samual Turnbull, Dinesh Selvakumar, Yasuhito Kotake, Chi-Jen Hsu, James J H Chong, Eddy Kizana, Saurabh Kumar","doi":"10.1016/j.jacep.2024.11.011","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.11.011","url":null,"abstract":"<p><strong>Background: </strong>Accurate electroanatomic mapping is critical for identifying scar and the long-term success of ventricular tachycardia ablation.</p><p><strong>Objectives: </strong>This study sought to determine the accuracy of multielectrode mapping (MEM) catheters to identify scar on cardiac magnetic resonance (CMR) and histopathology.</p><p><strong>Methods: </strong>In an ovine model of myocardial infarction, we examined the effect of electrode size, spacing, and mapping rhythm on scar identification compared to CMR and histopathology using 5 multielectrode mapping catheters. We co-registered electroanatomic mapping, CMR, and histopathology for comparison. Catheter-specific voltage thresholds were identified based on underlying amounts of normal myocardium on transmural histology biopsies.</p><p><strong>Results: </strong>Ten animals were included: 6 with anteroseptal myocardial infarction and 4 control animals. A total of 419,597 points were manually reviewed across the catheters, with 315,487 points used in the analysis. There were minimal differences in bipolar and unipolar voltages, scar areas, and abnormal electrograms between catheters and between rhythms. Catheter-specific bipolar and unipolar voltage thresholds for normal myocardium were High-Density Grid >2.78 mV and >6.19 mV, DuoDecapolar >2.22 mV and >6.05 mV, PentaRay >1.66 mV and >5.35 mV, Decanav >1.36 mV and >4.75 mV, Orion >1.21 mV and >6.05 mV, respectively. Catheter-specific bipolar thresholds improved the accuracy for detecting endo-mid myocardial scar on CMR by 1.8%-15.6% and catheter-specific unipolar thresholds improved the accuracy in the mid-epicardial layers by 25.3%-81.1%.</p><p><strong>Conclusions: </strong>Minimal differences were observed in scar detection and electrogram markers between commercially available multielectrode mapping catheters and differing wave fronts. Compared to traditional voltage criteria for bipolar and unipolar scar, catheter-specific thresholds markedly improved accuracy for delineating scar on CMR.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated Beat-to-Beat Measurement of R-Wave Peak Time for Left Bundle Branch Area Pacing.
IF 8 1区 医学
JACC. Clinical electrophysiology Pub Date : 2025-01-15 DOI: 10.1016/j.jacep.2024.10.035
Alberto Spadotto, Rune Paamand, Estel Clua I Sánchez, Valérian Valiton, Olivier Leonard, Karl Firth, Haran Burri
{"title":"Automated Beat-to-Beat Measurement of R-Wave Peak Time for Left Bundle Branch Area Pacing.","authors":"Alberto Spadotto, Rune Paamand, Estel Clua I Sánchez, Valérian Valiton, Olivier Leonard, Karl Firth, Haran Burri","doi":"10.1016/j.jacep.2024.10.035","DOIUrl":"https://doi.org/10.1016/j.jacep.2024.10.035","url":null,"abstract":"","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信